OncoTherapy Science Inc banner

OncoTherapy Science Inc
TSE:4564

Watchlist Manager
OncoTherapy Science Inc Logo
OncoTherapy Science Inc
TSE:4564
Watchlist
Price: 21 JPY -4.55%
Market Cap: ¥8.6B

Intrinsic Value

The intrinsic value for OncoTherapy Science Inc (4564) under the Base Case is 9.42 JPY. Compared with the current market price of 21 JPY, the stock appears Overvalued by 55% .

Intrinsic value calculated using DCF
¥9.42
Other reference points

Do our valuations actually work? See backtest results .

Intrinsic Value
¥9.42
Overvaluation 55%
Intrinsic Value
Price ¥21
Monitor OncoTherapy Science Inc
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ¥7.53
Get notified when the price drops into your buy zone
Current Price ¥21
Intrinsic Value ¥9.42
Margin of Safety 20% ¥7.53
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about OncoTherapy Science Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is OncoTherapy Science Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for OncoTherapy Science Inc.

Explain Valuation
Alternatives to OncoTherapy Science Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one OncoTherapy Science Inc stock?

The intrinsic value for OncoTherapy Science Inc (4564) under the Base Case is 9.42 JPY.

Is OncoTherapy Science Inc stock undervalued or overvalued?

Compared with the current market price of 21 JPY, the stock appears Overvalued by 55% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett